Scientists Turn Personal Illness into Research Drive for Rare Diseases
Researchers who themselves suffer from rare conditions are leading studies and advocacy efforts to improve diagnosis and treatment.
Francesca Granata endured severe skin pain in childhood before receiving a diagnosis of erythropoietic protoporphyria in 2008; she now works as a specialist in rare haematological disorders at a Milan research hospital and founded both an Italian patient-advocacy group and a global network for porphyria. Sonia Vallabh, who inherited a prion-protein gene mutation after her mother’s fatal prion disease, abandoned a legal career to study science and now co-directs a Broad Institute initiative evaluating siRNA-based drugs in a trial aimed at lowering normal prion protein in symptomatic patients.
Physician-researcher David Fajgenbaum, identified with Castleman disease during medical school, highlights the importance of collaborative oversight to avoid false patterns in research driven by personal experience. The interviewees note that personal stakes can foster empathy, motivate advocacy, and shape trial design, while also requiring strategies such as compartmentalisation to maintain objectivity.
Why it matters
Patient-researchers can bridge gaps in rare-disease knowledge, accelerating therapies and improving trial design.
In this story
